Literature DB >> 17497106

Targeting of matrix metalloproteinase activation for noninvasive detection of vulnerable atherosclerotic lesions.

Dagmar Hartung1, Michael Schäfers, Shinichiro Fujimoto, Bodo Levkau, Navneet Narula, Klaus Kopka, Renu Virmani, Chris Reutelingsperger, Leo Hofstra, Frank D Kolodgie, Artiom Petrov, Jagat Narula.   

Abstract

INTRODUCTION: Inflammation plays an important role in vulnerability of atherosclerotic plaques to rupture and hence acute coronary events. The monocyte-macrophage infiltration in plaques leads to upregulation of cytokines and metalloproteinase enzymes. Matrix metalloproteinases result in matrix dissolution and consequently expansive remodeling of the vessel. They also contribute to attenuation of fibrous cap and hence susceptibility to rupture. Assessment of metalloproteinase expression and activity should provide information about plaque instability.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17497106     DOI: 10.1007/s00259-007-0435-0

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  14 in total

Review 1.  Multimodality cardiovascular molecular imaging technology.

Authors:  Matthew O'Donnell; Elliot R McVeigh; H William Strauss; Atsushi Tanaka; Brett E Bouma; Guillermo J Tearney; Michael A Guttman; Ernest V Garcia
Journal:  J Nucl Med       Date:  2010-05-01       Impact factor: 10.057

2.  Assessing global cardiovascular molecular calcification with 18F-fluoride PET/CT: will this become a clinical reality and a challenge to CT calcification scoring?

Authors:  Sandip Basu; Poul F Høilund-Carlsen; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-04       Impact factor: 9.236

3.  Imaging with radiolabelled anti-membrane type 1 matrix metalloproteinase (MT1-MMP) antibody: potentials for characterizing atherosclerotic plaques.

Authors:  Yuji Kuge; Nozomi Takai; Yuki Ogawa; Takashi Temma; Yan Zhao; Kantaro Nishigori; Seigo Ishino; Junko Kamihashi; Yasushi Kiyono; Masashi Shiomi; Hideo Saji
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-07-13       Impact factor: 9.236

Review 4.  Non-FDG imaging of atherosclerosis: will imaging of MMPs assess plaque vulnerability?

Authors:  Sven Hermann; Andrea Starsichova; Bianca Waschkau; Michael Kuhlmann; Christian Wenning; Otmar Schober; Michael Schäfers
Journal:  J Nucl Cardiol       Date:  2012-06       Impact factor: 5.952

5.  Radiolabelled probes for imaging of atherosclerotic plaques.

Authors:  Takashi Temma; Hideo Saji
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-10-15

6.  Role of myocardial perfusion scintigraphy post invasive coronary angiography in patients with Myocardial Infarction.

Authors:  Cnb Harisankar; Bhagwant Rai Mittal; Kk Kamaleshwaran; Anish Bhattacharya; Baljinder Singh; Rajiv Mahajan
Journal:  Indian J Nucl Med       Date:  2010-04

7.  Towards Optimized Bioavailability of 99mTc-Labeled Barbiturates for Non-invasive Imaging of Matrix Metalloproteinase Activity.

Authors:  Lisa Honold; Melanie Austrup; Andreas Faust; Christian Paul Konken; Katrin Schwegmann; Bastian Zinnhardt; Constantin Gabriel Daniliuc; Günter Haufe; Michael Schäfers; Klaus Kopka; Sven Hermann
Journal:  Mol Imaging Biol       Date:  2021-11-08       Impact factor: 3.484

Review 8.  Recognition of Immune Response for the Early Diagnosis and Treatment of Osteoarthritis.

Authors:  Adrese M Kandahari; Xinlin Yang; Abhijit S Dighe; Dongfeng Pan; Quanjun Cui
Journal:  J Immunol Res       Date:  2015-05-03       Impact factor: 4.818

Review 9.  Clinical Utility and Future Applications of PET/CT and PET/CMR in Cardiology.

Authors:  Jonathan A Pan; Michael Salerno
Journal:  Diagnostics (Basel)       Date:  2016-09-02

Review 10.  PET imaging of inflammation biomarkers.

Authors:  Chenxi Wu; Fang Li; Gang Niu; Xiaoyuan Chen
Journal:  Theranostics       Date:  2013-06-24       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.